About
Contact & Profiles
A5092617177
Research Areas
- Pharmacovigilance and Adverse Drug Reactions
- Pharmaceutical Practices and Patient Outcomes
- Antibiotic Use and Resistance
- Drug-Induced Adverse Reactions
- Biosimilars and Bioanalytical Methods
Pharmo Institute
2023-2025
Utrecht University
2023-2025
ABSTRACT Purpose Fluoroquinolones are antibiotics associated with adverse events that prompted the European Medicines Agency to implement risk minimization measures (RMMs) in 2018/19 and 2020. Our aim is assess RMMs' impact on antibiotic prescriptions primary care during 2014–2023. Methods We assessed using CPRD GOLD (the United Kingdom, UK) PHARMO Netherlands, NL). Prescriptions were for fluoroquinolones alternative antibiotics. The of RMMs prescribing was interrupted time series (ITS)...
10.1002/pds.70081
article
EN
cc-by
Pharmacoepidemiology and Drug Safety
2025-01-16
Coming Soon ...